Clinical trials
Phase 2 Recurrence trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 2 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese University of Hong Kong | 3 |
| AstraZeneca | 1 |
| Clovis Oncology, Inc. | 1 |
| Eisai Inc. | 1 |
| National University Hospital, Singapore | 1 |
| Novartis Pharmaceuticals | 1 |
| Rain Oncology Inc | 1 |
| The University of Hong Kong | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 10 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Nasopharyngeal Carcinoma | 2 |
| Nasopharyngeal Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Disorders of Sex Development | 1 |
| Epstein-Barr Virus Infections | 1 |
| Lymphoma, B-Cell | 1 |
| Lymphoma, Follicular | 1 |
| Lymphoma, Non-Hodgkin | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.